Making the choice to vaccinate or not to vaccinate has become a difficult and sometimes contentious issue in the United States and the globe. But it’s not just your newborn child who is targeted. Adults over 65 have been added as eligible for conquest by Pfizer’s Prevnar 13, the pneumococcal pneumonia vaccine with $6.4 billion market, and currently the number one selling vaccination in the world. The marketing and regulatory schemes to jab Prevnar 13 into your grandparents veins is no different than “Merck’s Gardasil franchise” pushing the HPV boys age 12 and 13 in the U.K.
Read more here: Study shows unvaccinated children are less prone to disease